HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Intraperitoneal alpha-radioimmunotherapy in mice using different specific activities.

AbstractPURPOSE:
The aim of this study was to investigate the therapeutic efficacy of the alpha-radioimmunotherapy of ovarian cancer in mice, using different specific activities. This study was performed by using the monoclonal antibody, MX35 F(ab')(2), labeled with the alpha-particle-emitter, 211At.
METHODS:
Animals were intraperitoneally inoculated with approximately 1 x 10(7) cells of the cell line, NIH:OVCAR-3. Four (4) weeks later, five groups of animals were given 400 kBq of 211At-MX35 F(ab')(2) with specific activities equal to 130, 65, 32, 16, or 4 kBq/microg, respectively (n = 18 in each group). As controls, animals were given unlabeled MX35 F(ab')(2) (n = 12). Eight (8) weeks after treatment, the animals were sacrificed and the presence of macro- and microscopic tumors and ascites was determined.
RESULTS:
The tumor-free fractions (TFFs) of the animals, defined as the fraction of animals with no macro- and microtumors and no ascites, were 0.67, 0.73, 0.50, 0.50, and 0.17 when treated as above. Only the TFF of 0.17, for the specific activity of 4 kBq/microg, was significantly less, compared to that of the specific activity of 130 kBq/microg. The TFF for the specific activity of 4 kBq/microg showed a significant lowering, compared to the specific activity of 130 kBq/microg (p < 0.05). Treatment with unlabeled MX35 F(ab')(2) resulted in a TFF of zero.
CONCLUSIONS:
A specific activity-dependent therapeutic outcome could not be shown in the interval of 130- to 16 kBq/mug. For lower specific activities (i.e., 4 kBq/microg), the therapeutic efficacy was significantly lowered.
AuthorsJörgen Elgqvist, Håkan Andersson, Elin Haglund, Holger Jensen, Helena Kahu, Sture Lindegren, Elisabet Warnhammar, Ragnar Hultborn
JournalCancer biotherapy & radiopharmaceuticals (Cancer Biother Radiopharm) Vol. 24 Issue 4 Pg. 509-13 (Aug 2009) ISSN: 1557-8852 [Electronic] United States
PMID19694586 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies, Monoclonal
Topics
  • Alpha Particles
  • Animals
  • Antibodies, Monoclonal (administration & dosage, chemistry)
  • Cell Line, Tumor
  • Disease Models, Animal
  • Female
  • Infusions, Parenteral
  • Mice
  • Ovarian Neoplasms (immunology, radiotherapy)
  • Radioimmunotherapy (methods)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: